

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * collagen fibril organization (GO:0030199) | 5.34287831 |
| 2 | keratan sulfate catabolic process (GO:0042340) | 4.69439035 |
| 3 | glycolytic process (GO:0006096) | 4.59922566 |
| 4 | chondrocyte proliferation (GO:0035988) | 4.59015706 |
| 5 | COPII vesicle coating (GO:0048208) | 4.56754133 |
| 6 | endodermal cell differentiation (GO:0035987) | 4.52363063 |
| 7 | protein heterotrimerization (GO:0070208) | 4.41817158 |
| 8 | * peptidyl-proline hydroxylation (GO:0019511) | 3.98361566 |
| 9 | * 4-hydroxyproline metabolic process (GO:0019471) | 3.92167040 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.86292981 |
| 11 | collagen metabolic process (GO:0032963) | 3.79175502 |
| 12 | cell adhesion mediated by integrin (GO:0033627) | 3.76663274 |
| 13 | collagen catabolic process (GO:0030574) | 3.75251449 |
| 14 | basement membrane organization (GO:0071711) | 3.70303985 |
| 15 | dermatan sulfate biosynthetic process (GO:0030208) | 3.57560977 |
| 16 | chondrocyte development (GO:0002063) | 3.54354238 |
| 17 | glucose 6-phosphate metabolic process (GO:0051156) | 3.53738570 |
| 18 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.48760394 |
| 19 | negative regulation of fatty acid transport (GO:2000192) | 3.47434002 |
| 20 | craniofacial suture morphogenesis (GO:0097094) | 3.47177027 |
| 21 | * protein hydroxylation (GO:0018126) | 3.46189323 |
| 22 | cellular response to vitamin D (GO:0071305) | 3.45244291 |
| 23 | dermatan sulfate metabolic process (GO:0030205) | 3.39544398 |
| 24 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.39150485 |
| 25 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.39150485 |
| 26 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.38221413 |
| 27 | wound healing, spreading of epidermal cells (GO:0035313) | 3.37485837 |
| 28 | multicellular organismal catabolic process (GO:0044243) | 3.37469779 |
| 29 | vesicle coating (GO:0006901) | 3.35516024 |
| 30 | apoptotic cell clearance (GO:0043277) | 3.34499734 |
| 31 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.34142445 |
| 32 | axon extension involved in axon guidance (GO:0048846) | 3.34142445 |
| 33 | cellular response to vitamin (GO:0071295) | 3.31433390 |
| 34 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.29419746 |
| 35 | extracellular matrix disassembly (GO:0022617) | 3.27850794 |
| 36 | bone trabecula formation (GO:0060346) | 3.27188149 |
| 37 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.27136781 |
| 38 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.26749622 |
| 39 | multicellular organismal metabolic process (GO:0044236) | 3.24926332 |
| 40 | pyruvate metabolic process (GO:0006090) | 3.24436059 |
| 41 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.18386733 |
| 42 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.16099725 |
| 43 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.15996774 |
| 44 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.15955725 |
| 45 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.09508684 |
| 46 | Golgi transport vesicle coating (GO:0048200) | 3.08248682 |
| 47 | COPI coating of Golgi vesicle (GO:0048205) | 3.08248682 |
| 48 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.06797050 |
| 49 | positive regulation of mitochondrial fission (GO:0090141) | 3.06747721 |
| 50 | paraxial mesoderm development (GO:0048339) | 3.05643473 |
| 51 | negative regulation of axon guidance (GO:1902668) | 3.04366990 |
| 52 | cranial suture morphogenesis (GO:0060363) | 3.02931556 |
| 53 | skin morphogenesis (GO:0043589) | 3.01971519 |
| 54 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.99838426 |
| 55 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.98388297 |
| 56 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.95197663 |
| 57 | response to interferon-alpha (GO:0035455) | 2.95196216 |
| 58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.94902081 |
| 59 | modulation by symbiont of host immune response (GO:0052553) | 2.94902081 |
| 60 | positive regulation by symbiont of host defense response (GO:0052509) | 2.94902081 |
| 61 | modulation by symbiont of host defense response (GO:0052031) | 2.94902081 |
| 62 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.94902081 |
| 63 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.94902081 |
| 64 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.94025800 |
| 65 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.93373945 |
| 66 | substrate-dependent cell migration (GO:0006929) | 2.92820096 |
| 67 | cholesterol biosynthetic process (GO:0006695) | 2.91136103 |
| 68 | positive regulation of osteoblast proliferation (GO:0033690) | 2.90754832 |
| 69 | type B pancreatic cell proliferation (GO:0044342) | 2.86106121 |
| 70 | protein retention in ER lumen (GO:0006621) | 2.85653060 |
| 71 | regulation of plasminogen activation (GO:0010755) | 2.84833368 |
| 72 | negative chemotaxis (GO:0050919) | 2.83771284 |
| 73 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.81707803 |
| 74 | neutrophil activation involved in immune response (GO:0002283) | 2.81123652 |
| 75 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.80572313 |
| 76 | protein carboxylation (GO:0018214) | 2.80572313 |
| 77 | facial nerve structural organization (GO:0021612) | 2.79065997 |
| 78 | endocardial cushion development (GO:0003197) | 2.77667656 |
| 79 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.73971530 |
| 80 | wound healing, spreading of cells (GO:0044319) | 2.70031802 |
| 81 | lung vasculature development (GO:0060426) | 2.68030365 |
| 82 | blood vessel maturation (GO:0001955) | 2.67839292 |
| 83 | ER overload response (GO:0006983) | 2.67689756 |
| 84 | * extracellular matrix organization (GO:0030198) | 2.66230077 |
| 85 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.65099665 |
| 86 | * extracellular structure organization (GO:0043062) | 2.64972863 |
| 87 | glomerular basement membrane development (GO:0032836) | 2.64346317 |
| 88 | regulation of axon guidance (GO:1902667) | 2.64049924 |
| 89 | fibril organization (GO:0097435) | 2.62880562 |
| 90 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.62862107 |
| 91 | membrane budding (GO:0006900) | 2.62456762 |
| 92 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.59977253 |
| 93 | embryonic foregut morphogenesis (GO:0048617) | 2.59506796 |
| 94 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.59175695 |
| 95 | endothelial cell morphogenesis (GO:0001886) | 2.58508893 |
| 96 | sterol biosynthetic process (GO:0016126) | 2.57980132 |
| 97 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.56862268 |
| 98 | positive regulation of nuclease activity (GO:0032075) | 2.54591987 |
| 99 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.53211688 |
| 100 | plasma lipoprotein particle assembly (GO:0034377) | 2.52989156 |
| 101 | endothelial cell proliferation (GO:0001935) | 2.52414179 |
| 102 | phagocytosis, recognition (GO:0006910) | 2.52111490 |
| 103 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.51334678 |
| 104 | negative regulation of fibrinolysis (GO:0051918) | 2.49463144 |
| 105 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.48426564 |
| 106 | positive regulation of macrophage differentiation (GO:0045651) | 2.48253600 |
| 107 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.48025492 |
| 108 | cellular response to interferon-alpha (GO:0035457) | 2.47799997 |
| 109 | ER-nucleus signaling pathway (GO:0006984) | 2.47684148 |
| 110 | mesenchymal cell proliferation (GO:0010463) | 2.45580534 |
| 111 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.45503300 |
| 112 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.45498664 |
| 113 | polarized epithelial cell differentiation (GO:0030859) | 2.44261844 |
| 114 | cellular copper ion homeostasis (GO:0006878) | 2.43340588 |
| 115 | peptidyl-asparagine modification (GO:0018196) | 2.42340353 |
| 116 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.41315992 |
| 117 | establishment of tissue polarity (GO:0007164) | 2.40592342 |
| 118 | establishment of planar polarity (GO:0001736) | 2.40592342 |
| 119 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.39929909 |
| 120 | muscle cell cellular homeostasis (GO:0046716) | 2.39274540 |
| 121 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.39236949 |
| 122 | response to follicle-stimulating hormone (GO:0032354) | 2.37314942 |
| 123 | positive regulation of p38MAPK cascade (GO:1900745) | 2.36200690 |
| 124 | cellular response to unfolded protein (GO:0034620) | 2.35255670 |
| 125 | glycoprotein catabolic process (GO:0006516) | 2.35069263 |
| 126 | protein localization to cell surface (GO:0034394) | 2.35057116 |
| 127 | negative regulation of biomineral tissue development (GO:0070168) | 2.34987911 |
| 128 | regulation of chondrocyte differentiation (GO:0032330) | 2.34883345 |
| 129 | mRNA transcription (GO:0009299) | 2.34844039 |
| 130 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.34417256 |
| 131 | hyaluronan catabolic process (GO:0030214) | 2.34361821 |
| 132 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.34243876 |
| 133 | cochlea morphogenesis (GO:0090103) | 2.34152065 |
| 134 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.34067552 |
| 135 | regulation of cardioblast differentiation (GO:0051890) | 2.33996097 |
| 136 | negative regulation of cartilage development (GO:0061037) | 2.32064911 |
| 137 | protein N-linked glycosylation (GO:0006487) | 2.32042756 |
| 138 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.31856117 |
| 139 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.31663725 |
| 140 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.30811585 |
| 141 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.30460279 |
| 142 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.30118568 |
| 143 | anterior/posterior axis specification (GO:0009948) | 2.29647544 |
| 144 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.29353871 |
| 145 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.29232719 |
| 146 | face morphogenesis (GO:0060325) | 2.27726355 |
| 147 | phagocytosis, engulfment (GO:0006911) | 2.27265258 |
| 148 | keratan sulfate metabolic process (GO:0042339) | 2.27071283 |
| 149 | positive regulation of chemokine secretion (GO:0090197) | 2.25489515 |
| 150 | regulation of necroptotic process (GO:0060544) | 2.24878048 |
| 151 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.24241860 |
| 152 | response to vitamin D (GO:0033280) | 2.24079731 |
| 153 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.23618881 |
| 154 | pinocytosis (GO:0006907) | 2.23576912 |
| 155 | positive regulation of metanephros development (GO:0072216) | 2.23417355 |
| 156 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.22718812 |
| 157 | pattern specification involved in kidney development (GO:0061004) | 2.22032886 |
| 158 | response to peptidoglycan (GO:0032494) | 2.20621083 |
| 159 | positive regulation of cartilage development (GO:0061036) | 2.20555832 |
| 160 | extracellular fibril organization (GO:0043206) | 2.20414929 |
| 161 | muscle cell migration (GO:0014812) | 2.20264906 |
| 162 | response to fluid shear stress (GO:0034405) | 2.19787123 |
| 163 | regulation of monocyte chemotaxis (GO:0090025) | 2.17299154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.63739890 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.73869163 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.20586896 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.99602493 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.77706381 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60454583 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.39466607 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.20443060 |
| 9 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.83506381 |
| 10 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.79338078 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.64072568 |
| 12 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.63979677 |
| 13 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.62658312 |
| 14 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.59291668 |
| 15 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.57074902 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.49456717 |
| 17 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.44902872 |
| 18 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.40959095 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.36992694 |
| 20 | CJUN_26792858_Chip-Seq_BT549_Human | 2.29790268 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.28738787 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19354789 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.17590221 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.16514461 |
| 25 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13014854 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10067427 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.08329934 |
| 28 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.07683220 |
| 29 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.05810410 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01132458 |
| 31 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.00348137 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94915275 |
| 33 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.93477018 |
| 34 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.92558643 |
| 35 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.92558643 |
| 36 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87938557 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86961835 |
| 38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.85301150 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.83043745 |
| 40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.80700382 |
| 41 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.78882846 |
| 42 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.78882846 |
| 43 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76871987 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76832739 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72378542 |
| 46 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.71497575 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69923443 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67696909 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.66350453 |
| 50 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.63667561 |
| 51 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.62945099 |
| 52 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62541887 |
| 53 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.61549348 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61125165 |
| 55 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.61034354 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56264659 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.54093280 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51555354 |
| 59 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.51477786 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50295633 |
| 61 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50164350 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49360481 |
| 63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.47978853 |
| 64 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.47196425 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.47054320 |
| 66 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.45886307 |
| 67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.45626415 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45232786 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42794117 |
| 70 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.41089711 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40936007 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40428463 |
| 73 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38923686 |
| 74 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35819398 |
| 75 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.34796960 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33107929 |
| 77 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32975221 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32385810 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32280248 |
| 80 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31047295 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.29621038 |
| 82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29000854 |
| 83 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.28568469 |
| 84 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.27988853 |
| 85 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.27544492 |
| 86 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.26360609 |
| 87 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23625287 |
| 88 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23405138 |
| 89 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22799875 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.22325598 |
| 91 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21956438 |
| 92 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.21807137 |
| 93 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.21641976 |
| 94 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.21587655 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21393906 |
| 96 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.21380885 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20776534 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19816416 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19123013 |
| 100 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.18335389 |
| 101 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17325215 |
| 102 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17133292 |
| 103 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16212728 |
| 104 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15141992 |
| 105 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14267201 |
| 106 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12067537 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 1.12038929 |
| 108 | * GBX2_23144817_ChIP-Seq_PC3_Human | 1.11880460 |
| 109 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11629091 |
| 110 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10780139 |
| 111 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10478015 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09648294 |
| 113 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.06283046 |
| 114 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05537070 |
| 115 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04631861 |
| 116 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.03602215 |
| 117 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03298014 |
| 118 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 1.03153073 |
| 119 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02801055 |
| 120 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02118004 |
| 121 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01001599 |
| 122 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00737111 |
| 123 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.00148960 |
| 124 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00023535 |
| 125 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00009856 |
| 126 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.00004350 |
| 127 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98543504 |
| 128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98445967 |
| 129 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96928698 |
| 130 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94907831 |
| 131 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.93549646 |
| 132 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92813057 |
| 133 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92770974 |
| 134 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92241618 |
| 135 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92186369 |
| 136 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92074249 |
| 137 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.91784863 |
| 138 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90880225 |
| 139 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.89757962 |
| 140 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89250159 |
| 141 | * MAF_26560356_Chip-Seq_TH1_Human | 0.89244945 |
| 142 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88812934 |
| 143 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88685270 |
| 144 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.88353984 |
| 145 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88308296 |
| 146 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88302011 |
| 147 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.87621163 |
| 148 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.86348819 |
| 149 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86139266 |
| 150 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.86090340 |
| 151 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85970847 |
| 152 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85759292 |
| 153 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85695932 |
| 154 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85695020 |
| 155 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85028498 |
| 156 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85028498 |
| 157 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84789301 |
| 158 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.84597622 |
| 159 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84411517 |
| 160 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83092209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.26331496 |
| 2 | MP0005503_abnormal_tendon_morphology | 4.35078766 |
| 3 | MP0005275_abnormal_skin_tensile | 3.84582735 |
| 4 | MP0003279_aneurysm | 3.18326227 |
| 5 | MP0001958_emphysema | 2.91962255 |
| 6 | MP0005623_abnormal_meninges_morphology | 2.86438450 |
| 7 | * MP0004272_abnormal_basement_membrane | 2.86119235 |
| 8 | MP0009384_cardiac_valve_regurgitation | 2.83343300 |
| 9 | MP0003122_maternal_imprinting | 2.63866808 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.42718042 |
| 11 | MP0006054_spinal_hemorrhage | 2.40915925 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.23827538 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.12123174 |
| 14 | MP0002933_joint_inflammation | 2.09707621 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.05315454 |
| 16 | MP0005508_abnormal_skeleton_morphology | 1.97852445 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.80632297 |
| 18 | MP0001542_abnormal_bone_strength | 1.80290539 |
| 19 | MP0003091_abnormal_cell_migration | 1.74230786 |
| 20 | MP0001533_abnormal_skeleton_physiology | 1.67975821 |
| 21 | MP0005390_skeleton_phenotype | 1.67382180 |
| 22 | MP0005023_abnormal_wound_healing | 1.63479721 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 1.56291343 |
| 24 | MP0000762_abnormal_tongue_morphology | 1.56117470 |
| 25 | MP0002896_abnormal_bone_mineralization | 1.55955967 |
| 26 | MP0009250_abnormal_appendicular_skeleto | 1.52610592 |
| 27 | MP0002998_abnormal_bone_remodeling | 1.52557011 |
| 28 | MP0002938_white_spotting | 1.49457129 |
| 29 | MP0003890_abnormal_embryonic-extraembry | 1.49271404 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.45269897 |
| 31 | MP0002233_abnormal_nose_morphology | 1.43011792 |
| 32 | MP0000767_abnormal_smooth_muscle | 1.39304896 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.37413973 |
| 34 | MP0002295_abnormal_pulmonary_circulatio | 1.35477432 |
| 35 | MP0005171_absent_coat_pigmentation | 1.34692011 |
| 36 | MP0004134_abnormal_chest_morphology | 1.33221397 |
| 37 | MP0002282_abnormal_trachea_morphology | 1.32225558 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.31514218 |
| 39 | MP0002060_abnormal_skin_morphology | 1.31462911 |
| 40 | MP0002115_abnormal_skeleton_extremities | 1.31168053 |
| 41 | MP0000163_abnormal_cartilage_morphology | 1.29623691 |
| 42 | MP0008007_abnormal_cellular_replicative | 1.28902215 |
| 43 | MP0001299_abnormal_eye_distance/ | 1.26126512 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.25482556 |
| 45 | MP0002113_abnormal_skeleton_development | 1.24806405 |
| 46 | MP0000733_abnormal_muscle_development | 1.22221708 |
| 47 | MP0003436_decreased_susceptibility_to | 1.19843022 |
| 48 | MP0002697_abnormal_eye_size | 1.18033047 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.17703737 |
| 50 | MP0003385_abnormal_body_wall | 1.16978387 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.13424920 |
| 52 | MP0003795_abnormal_bone_structure | 1.13347917 |
| 53 | MP0001286_abnormal_eye_development | 1.12599596 |
| 54 | MP0002108_abnormal_muscle_morphology | 1.12016767 |
| 55 | MP0003724_increased_susceptibility_to | 1.10598336 |
| 56 | MP0001915_intracranial_hemorrhage | 1.09929904 |
| 57 | MP0003303_peritoneal_inflammation | 1.09567148 |
| 58 | MP0002092_abnormal_eye_morphology | 1.08273294 |
| 59 | MP0000343_altered_response_to | 1.07871806 |
| 60 | MP0009697_abnormal_copulation | 1.06395340 |
| 61 | MP0000428_abnormal_craniofacial_morphol | 1.04915251 |
| 62 | MP0005164_abnormal_response_to | 1.04890698 |
| 63 | MP0003448_altered_tumor_morphology | 1.03359332 |
| 64 | MP0010030_abnormal_orbit_morphology | 1.02233640 |
| 65 | MP0005197_abnormal_uvea_morphology | 1.01891906 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.01486735 |
| 67 | MP0002419_abnormal_innate_immunity | 1.00358090 |
| 68 | MP0003935_abnormal_craniofacial_develop | 0.99829742 |
| 69 | MP0003828_pulmonary_edema | 0.99497173 |
| 70 | MP0010307_abnormal_tumor_latency | 0.98580100 |
| 71 | MP0003136_yellow_coat_color | 0.96202832 |
| 72 | MP0005408_hypopigmentation | 0.96115250 |
| 73 | MP0003045_fibrosis | 0.95206785 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.94966361 |
| 75 | MP0000858_altered_metastatic_potential | 0.94544959 |
| 76 | MP0000751_myopathy | 0.93865184 |
| 77 | MP0001835_abnormal_antigen_presentation | 0.92807748 |
| 78 | MP0004858_abnormal_nervous_system | 0.92299446 |
| 79 | MP0005187_abnormal_penis_morphology | 0.91464240 |
| 80 | MP0003115_abnormal_respiratory_system | 0.90762885 |
| 81 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90182396 |
| 82 | MP0003941_abnormal_skin_development | 0.89849825 |
| 83 | MP0001243_abnormal_dermal_layer | 0.89025355 |
| 84 | MP0001293_anophthalmia | 0.88552754 |
| 85 | MP0000534_abnormal_ureter_morphology | 0.87921599 |
| 86 | MP0003942_abnormal_urinary_system | 0.87478964 |
| 87 | MP0005248_abnormal_Harderian_gland | 0.86911941 |
| 88 | MP0002148_abnormal_hypersensitivity_rea | 0.85947510 |
| 89 | MP0002109_abnormal_limb_morphology | 0.85674751 |
| 90 | MP0000685_abnormal_immune_system | 0.84864941 |
| 91 | MP0004084_abnormal_cardiac_muscle | 0.84687004 |
| 92 | MP0002084_abnormal_developmental_patter | 0.83197346 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.82826143 |
| 94 | MP0000639_abnormal_adrenal_gland | 0.82213141 |
| 95 | MP0001175_abnormal_lung_morphology | 0.81713194 |
| 96 | MP0000749_muscle_degeneration | 0.81674368 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.81388685 |
| 98 | MP0002177_abnormal_outer_ear | 0.80709502 |
| 99 | MP0003315_abnormal_perineum_morphology | 0.79403771 |
| 100 | MP0009785_altered_susceptibility_to | 0.78260022 |
| 101 | MP0003283_abnormal_digestive_organ | 0.76904429 |
| 102 | MP0002925_abnormal_cardiovascular_devel | 0.76888218 |
| 103 | MP0002111_abnormal_tail_morphology | 0.76736674 |
| 104 | * MP0001614_abnormal_blood_vessel | 0.76692372 |
| 105 | MP0000747_muscle_weakness | 0.76186790 |
| 106 | MP0000049_abnormal_middle_ear | 0.75465468 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.75371308 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.74949871 |
| 109 | MP0008932_abnormal_embryonic_tissue | 0.74256700 |
| 110 | MP0005193_abnormal_anterior_eye | 0.73723875 |
| 111 | MP0002269_muscular_atrophy | 0.73233609 |
| 112 | MP0002139_abnormal_hepatobiliary_system | 0.72727894 |
| 113 | MP0000013_abnormal_adipose_tissue | 0.72585274 |
| 114 | MP0002168_other_aberrant_phenotype | 0.72481029 |
| 115 | MP0000750_abnormal_muscle_regeneration | 0.72302095 |
| 116 | MP0003121_genomic_imprinting | 0.71638674 |
| 117 | MP0002116_abnormal_craniofacial_bone | 0.71338819 |
| 118 | MP0002396_abnormal_hematopoietic_system | 0.70742227 |
| 119 | MP0004233_abnormal_muscle_weight | 0.69550679 |
| 120 | MP0002128_abnormal_blood_circulation | 0.69398536 |
| 121 | MP0000778_abnormal_nervous_system | 0.68544076 |
| 122 | * MP0003984_embryonic_growth_retardation | 0.67543922 |
| 123 | MP0005000_abnormal_immune_tolerance | 0.67495501 |
| 124 | MP0003755_abnormal_palate_morphology | 0.67188128 |
| 125 | MP0000647_abnormal_sebaceous_gland | 0.66673315 |
| 126 | MP0009333_abnormal_splenocyte_physiolog | 0.66655924 |
| 127 | MP0000432_abnormal_head_morphology | 0.66629596 |
| 128 | MP0002090_abnormal_vision | 0.66621810 |
| 129 | MP0008004_abnormal_stomach_pH | 0.66059859 |
| 130 | MP0005391_vision/eye_phenotype | 0.65903020 |
| 131 | MP0001177_atelectasis | 0.65097254 |
| 132 | MP0002932_abnormal_joint_morphology | 0.64644663 |
| 133 | MP0001879_abnormal_lymphatic_vessel | 0.64607357 |
| 134 | MP0002133_abnormal_respiratory_system | 0.64540749 |
| 135 | MP0005388_respiratory_system_phenotype | 0.64540749 |
| 136 | * MP0002088_abnormal_embryonic_growth/wei | 0.64342095 |
| 137 | MP0004264_abnormal_extraembryonic_tissu | 0.64052949 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.64013522 |
| 139 | MP0009278_abnormal_bone_marrow | 0.63898019 |
| 140 | MP0003937_abnormal_limbs/digits/tail_de | 0.63842544 |
| 141 | MP0000490_abnormal_crypts_of | 0.63813977 |
| 142 | MP0006082_CNS_inflammation | 0.63585147 |
| 143 | MP0002114_abnormal_axial_skeleton | 0.63462662 |
| 144 | MP0005330_cardiomyopathy | 0.62567883 |
| 145 | * MP0001672_abnormal_embryogenesis/_devel | 0.61622779 |
| 146 | * MP0005380_embryogenesis_phenotype | 0.61622779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 7.07193186 |
| 2 | Protrusio acetabuli (HP:0003179) | 6.61068792 |
| 3 | Cervical subluxation (HP:0003308) | 4.91594834 |
| 4 | Ankle contracture (HP:0006466) | 4.51518151 |
| 5 | Abnormal gallbladder physiology (HP:0012438) | 4.25883514 |
| 6 | Cholecystitis (HP:0001082) | 4.25883514 |
| 7 | Aortic dissection (HP:0002647) | 4.18310588 |
| 8 | Soft skin (HP:0000977) | 3.93161989 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 3.81366849 |
| 10 | Shallow orbits (HP:0000586) | 3.65785043 |
| 11 | Neonatal short-limb short stature (HP:0008921) | 3.64005236 |
| 12 | Abnormality of dentin (HP:0010299) | 3.62700469 |
| 13 | Cerebral aneurysm (HP:0004944) | 3.61442188 |
| 14 | Epiphyseal dysplasia (HP:0002656) | 3.60177130 |
| 15 | Dilatation of the ascending aorta (HP:0005111) | 3.50804457 |
| 16 | Peritonitis (HP:0002586) | 3.47569315 |
| 17 | Abnormality of glycolysis (HP:0004366) | 3.42254310 |
| 18 | Vertebral compression fractures (HP:0002953) | 3.41097275 |
| 19 | Atrophic scars (HP:0001075) | 3.33524548 |
| 20 | Wormian bones (HP:0002645) | 3.26443157 |
| 21 | Bladder diverticulum (HP:0000015) | 3.14016016 |
| 22 | Aortic aneurysm (HP:0004942) | 3.11924108 |
| 23 | Cupped ribs (HP:0000887) | 3.05430282 |
| 24 | Mitral valve prolapse (HP:0001634) | 2.95407528 |
| 25 | Increased serum pyruvate (HP:0003542) | 2.93634142 |
| 26 | Blue sclerae (HP:0000592) | 2.87446796 |
| 27 | Biconcave vertebral bodies (HP:0004586) | 2.86127365 |
| 28 | Follicular hyperkeratosis (HP:0007502) | 2.79709791 |
| 29 | Genu recurvatum (HP:0002816) | 2.77983171 |
| 30 | Radial bowing (HP:0002986) | 2.76125151 |
| 31 | Beaking of vertebral bodies (HP:0004568) | 2.69364577 |
| 32 | Fragile skin (HP:0001030) | 2.64993372 |
| 33 | Knee flexion contracture (HP:0006380) | 2.60786990 |
| 34 | Abnormality of the acetabulum (HP:0003170) | 2.60786495 |
| 35 | Broad metatarsal (HP:0001783) | 2.59769837 |
| 36 | Hypoplastic ischia (HP:0003175) | 2.59397888 |
| 37 | Elbow flexion contracture (HP:0002987) | 2.57015116 |
| 38 | Type 1 muscle fiber predominance (HP:0003803) | 2.55904418 |
| 39 | Platyspondyly (HP:0000926) | 2.55367864 |
| 40 | Vascular tortuosity (HP:0004948) | 2.55234274 |
| 41 | Osteoarthritis (HP:0002758) | 2.52723744 |
| 42 | Coronal craniosynostosis (HP:0004440) | 2.52563895 |
| 43 | Spinal rigidity (HP:0003306) | 2.49076376 |
| 44 | Pterygium (HP:0001059) | 2.46261718 |
| 45 | Coxa vara (HP:0002812) | 2.44567444 |
| 46 | Wide anterior fontanel (HP:0000260) | 2.41742215 |
| 47 | Nuclear cataract (HP:0100018) | 2.41416013 |
| 48 | Joint laxity (HP:0001388) | 2.39833858 |
| 49 | Spondylolisthesis (HP:0003302) | 2.35355237 |
| 50 | Small epiphyses (HP:0010585) | 2.33559774 |
| 51 | Short nail (HP:0001799) | 2.31464279 |
| 52 | Abnormality of the ischium (HP:0003174) | 2.30661503 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.24156451 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24156451 |
| 55 | Ulnar bowing (HP:0003031) | 2.24057559 |
| 56 | Joint stiffness (HP:0001387) | 2.22711257 |
| 57 | Arterial tortuosity (HP:0005116) | 2.22560106 |
| 58 | Spinal cord compression (HP:0002176) | 2.21866889 |
| 59 | Femoral bowing (HP:0002980) | 2.20885312 |
| 60 | Mesomelia (HP:0003027) | 2.13078141 |
| 61 | Broad ribs (HP:0000885) | 2.12471442 |
| 62 | Mitral stenosis (HP:0001718) | 2.10960074 |
| 63 | Renal duplication (HP:0000075) | 2.10925968 |
| 64 | Inguinal hernia (HP:0000023) | 2.10735176 |
| 65 | Bell-shaped thorax (HP:0001591) | 2.09780452 |
| 66 | Mild short stature (HP:0003502) | 2.09543617 |
| 67 | Hypoplasia of the odontoid process (HP:0003311) | 2.09323510 |
| 68 | Abnormal delivery (HP:0001787) | 2.08978265 |
| 69 | Wrist flexion contracture (HP:0001239) | 2.08252072 |
| 70 | Rhizomelia (HP:0008905) | 2.08172037 |
| 71 | Bowed forearm bones (HP:0003956) | 2.07624661 |
| 72 | Bowing of the arm (HP:0006488) | 2.07624661 |
| 73 | Deep venous thrombosis (HP:0002625) | 2.06470366 |
| 74 | Ovoid vertebral bodies (HP:0003300) | 2.06462702 |
| 75 | Broad palm (HP:0001169) | 2.05469757 |
| 76 | Abnormality of the odontoid process (HP:0003310) | 2.03256047 |
| 77 | Irregular epiphyses (HP:0010582) | 2.00794249 |
| 78 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.99808350 |
| 79 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99291184 |
| 80 | Hyperextensible skin (HP:0000974) | 1.99095172 |
| 81 | Ankyloglossia (HP:0010296) | 1.97779184 |
| 82 | Persistence of primary teeth (HP:0006335) | 1.97020280 |
| 83 | Thin ribs (HP:0000883) | 1.95740235 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 1.94871008 |
| 85 | Metaphyseal cupping (HP:0003021) | 1.94524805 |
| 86 | Myoglobinuria (HP:0002913) | 1.93512428 |
| 87 | Exostoses (HP:0100777) | 1.92665263 |
| 88 | Mitral regurgitation (HP:0001653) | 1.91713438 |
| 89 | Spinal cord lesions (HP:0100561) | 1.91090700 |
| 90 | Syringomyelia (HP:0003396) | 1.91090700 |
| 91 | Slender build (HP:0001533) | 1.90437479 |
| 92 | Bifid tongue (HP:0010297) | 1.90001362 |
| 93 | Broad face (HP:0000283) | 1.89229745 |
| 94 | Flat acetabular roof (HP:0003180) | 1.88910589 |
| 95 | Morphological abnormality of the middle ear (HP:0008609) | 1.88424744 |
| 96 | Absent frontal sinuses (HP:0002688) | 1.87104537 |
| 97 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.86969983 |
| 98 | Ectopia lentis (HP:0001083) | 1.86386629 |
| 99 | Breech presentation (HP:0001623) | 1.86368263 |
| 100 | Hip contracture (HP:0003273) | 1.85166950 |
| 101 | Abnormal vertebral ossification (HP:0100569) | 1.84984139 |
| 102 | Ulnar deviation of the wrist (HP:0003049) | 1.83167781 |
| 103 | Camptodactyly of toe (HP:0001836) | 1.80925220 |
| 104 | Broad long bones (HP:0005622) | 1.80672112 |
| 105 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.80362119 |
| 106 | Bowel diverticulosis (HP:0005222) | 1.80165466 |
| 107 | Decreased skull ossification (HP:0004331) | 1.79397187 |
| 108 | Increased connective tissue (HP:0009025) | 1.79320039 |
| 109 | Hypoplasia of the iris (HP:0007676) | 1.78433397 |
| 110 | Protruding ear (HP:0000411) | 1.77001693 |
| 111 | Vertebral arch anomaly (HP:0008438) | 1.74940719 |
| 112 | Abnormality of skull ossification (HP:0002703) | 1.74664966 |
| 113 | Vitreoretinal degeneration (HP:0000655) | 1.74496980 |
| 114 | Delayed gross motor development (HP:0002194) | 1.74403518 |
| 115 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.74133298 |
| 116 | Vertebral hypoplasia (HP:0008417) | 1.74133298 |
| 117 | Aneurysm (HP:0002617) | 1.73513230 |
| 118 | Pulmonic stenosis (HP:0001642) | 1.72147965 |
| 119 | Tibial bowing (HP:0002982) | 1.72029748 |
| 120 | Craniofacial hyperostosis (HP:0004493) | 1.71883509 |
| 121 | Pectus carinatum (HP:0000768) | 1.71165765 |
| 122 | Flared iliac wings (HP:0002869) | 1.70844793 |
| 123 | Thoracolumbar scoliosis (HP:0002944) | 1.69734501 |
| 124 | Deviation of the hallux (HP:0010051) | 1.69703252 |
| 125 | Hypoalphalipoproteinemia (HP:0003233) | 1.69563180 |
| 126 | Osteopenia (HP:0000938) | 1.69027039 |
| 127 | Abnormality of carpal bone ossification (HP:0006257) | 1.69017037 |
| 128 | Abnormal ossification of hand bones (HP:0005921) | 1.68624814 |
| 129 | Abnormality of the calcaneus (HP:0008364) | 1.68289721 |
| 130 | Rhabdomyolysis (HP:0003201) | 1.68174475 |
| 131 | Limited hip movement (HP:0008800) | 1.68071355 |
| 132 | Abnormal hand bone ossification (HP:0010660) | 1.67367210 |
| 133 | Reticulocytosis (HP:0001923) | 1.66843518 |
| 134 | Cortical dysplasia (HP:0002539) | 1.66840230 |
| 135 | Aortic regurgitation (HP:0001659) | 1.66048490 |
| 136 | Papillary thyroid carcinoma (HP:0002895) | 1.65284087 |
| 137 | Abnormality of oral frenula (HP:0000190) | 1.63134842 |
| 138 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.61690079 |
| 139 | Limb-girdle muscle weakness (HP:0003325) | 1.61116757 |
| 140 | Tetraparesis (HP:0002273) | 1.60607034 |
| 141 | Abnormality of the intrinsic pathway (HP:0010989) | 1.59550241 |
| 142 | Hammertoe (HP:0001765) | 1.58800681 |
| 143 | Zonular cataract (HP:0010920) | 1.58800680 |
| 144 | Intrahepatic cholestasis (HP:0001406) | 1.58202145 |
| 145 | Microglossia (HP:0000171) | 1.57477025 |
| 146 | Short humerus (HP:0005792) | 1.57159280 |
| 147 | Deformed tarsal bones (HP:0008119) | 1.56989733 |
| 148 | Hydroxyprolinuria (HP:0003080) | 1.55387887 |
| 149 | Abnormality of proline metabolism (HP:0010907) | 1.55387887 |
| 150 | Increased corneal curvature (HP:0100692) | 1.54670947 |
| 151 | Keratoconus (HP:0000563) | 1.54670947 |
| 152 | Myelomeningocele (HP:0002475) | 1.54642776 |
| 153 | Disproportionate tall stature (HP:0001519) | 1.53379568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 4.29800170 |
| 2 | FLT3 | 4.02354571 |
| 3 | PKN2 | 3.73105108 |
| 4 | TRIB3 | 3.71070458 |
| 5 | BCR | 3.23480244 |
| 6 | TNIK | 3.08467994 |
| 7 | TTN | 2.82448318 |
| 8 | NEK1 | 2.69026639 |
| 9 | EIF2AK3 | 2.50063490 |
| 10 | PDGFRA | 2.49573467 |
| 11 | NME2 | 2.47967048 |
| 12 | NLK | 2.35766519 |
| 13 | RPS6KA4 | 2.35368308 |
| 14 | PIM2 | 2.26389849 |
| 15 | KIT | 2.23948532 |
| 16 | TGFBR2 | 2.03057382 |
| 17 | RIPK1 | 1.89881382 |
| 18 | TRIM28 | 1.87861240 |
| 19 | CAMKK2 | 1.87260192 |
| 20 | TRPM7 | 1.81862056 |
| 21 | ERBB4 | 1.69194224 |
| 22 | PBK | 1.68788286 |
| 23 | ERN1 | 1.63991301 |
| 24 | EPHA3 | 1.57685236 |
| 25 | STK38L | 1.57300670 |
| 26 | WEE1 | 1.54132704 |
| 27 | BCKDK | 1.52757849 |
| 28 | MOS | 1.48345086 |
| 29 | EIF2AK1 | 1.46758674 |
| 30 | AKT3 | 1.46524600 |
| 31 | NEK9 | 1.46411394 |
| 32 | MET | 1.45637261 |
| 33 | TBK1 | 1.40653049 |
| 34 | JAK3 | 1.40607362 |
| 35 | CSF1R | 1.34120156 |
| 36 | LRRK2 | 1.32537653 |
| 37 | BRD4 | 1.29702414 |
| 38 | MAP3K4 | 1.29242622 |
| 39 | FER | 1.27781861 |
| 40 | PAK4 | 1.25828778 |
| 41 | ARAF | 1.25429436 |
| 42 | PAK2 | 1.22874035 |
| 43 | IKBKB | 1.22237815 |
| 44 | ERBB3 | 1.21390162 |
| 45 | KSR1 | 1.21241334 |
| 46 | MAP3K3 | 1.19119785 |
| 47 | BMX | 1.12972198 |
| 48 | SRPK1 | 1.12955710 |
| 49 | PNCK | 1.09259751 |
| 50 | IRAK4 | 1.09038504 |
| 51 | JAK1 | 1.08618501 |
| 52 | NEK2 | 1.05515019 |
| 53 | MYLK | 1.04979352 |
| 54 | STK3 | 1.02309598 |
| 55 | TEC | 1.01110756 |
| 56 | ROCK2 | 1.00994436 |
| 57 | TGFBR1 | 1.00877286 |
| 58 | PDGFRB | 1.00177205 |
| 59 | FGFR4 | 0.98232386 |
| 60 | EIF2AK2 | 0.98043031 |
| 61 | WNK4 | 0.96123176 |
| 62 | SCYL2 | 0.95566980 |
| 63 | PRKG2 | 0.94820109 |
| 64 | ZAP70 | 0.94571592 |
| 65 | STK10 | 0.94026085 |
| 66 | MAP3K14 | 0.93685717 |
| 67 | ICK | 0.91973265 |
| 68 | PTK6 | 0.88912696 |
| 69 | EPHA2 | 0.87247659 |
| 70 | TYK2 | 0.86611190 |
| 71 | MKNK2 | 0.85822570 |
| 72 | LIMK1 | 0.83997778 |
| 73 | KSR2 | 0.83034650 |
| 74 | MKNK1 | 0.80565250 |
| 75 | ILK | 0.79744524 |
| 76 | FGFR1 | 0.79434724 |
| 77 | MAP3K6 | 0.77886057 |
| 78 | MAP2K7 | 0.77726094 |
| 79 | SIK1 | 0.77232290 |
| 80 | PTK2 | 0.76594092 |
| 81 | MAP3K9 | 0.75444612 |
| 82 | PLK3 | 0.74802959 |
| 83 | MUSK | 0.72959581 |
| 84 | EEF2K | 0.72890252 |
| 85 | MAP2K3 | 0.72261036 |
| 86 | BMPR1B | 0.72038844 |
| 87 | EPHB2 | 0.70834859 |
| 88 | PLK2 | 0.70762315 |
| 89 | YES1 | 0.68976748 |
| 90 | ZAK | 0.68859634 |
| 91 | LATS1 | 0.65769953 |
| 92 | MST4 | 0.65743765 |
| 93 | CSNK1A1L | 0.65743521 |
| 94 | RAF1 | 0.65403866 |
| 95 | STK24 | 0.64792455 |
| 96 | PDK2 | 0.63738144 |
| 97 | DYRK3 | 0.63232779 |
| 98 | CASK | 0.60671996 |
| 99 | HCK | 0.60570246 |
| 100 | CDK8 | 0.60161055 |
| 101 | ROCK1 | 0.59794533 |
| 102 | PRKCE | 0.59106967 |
| 103 | MAP3K8 | 0.58398830 |
| 104 | MAP3K12 | 0.58246155 |
| 105 | FES | 0.55329117 |
| 106 | IRAK3 | 0.55108072 |
| 107 | MAP4K2 | 0.54744478 |
| 108 | LATS2 | 0.54698899 |
| 109 | INSR | 0.54216435 |
| 110 | MST1R | 0.54002477 |
| 111 | WNK1 | 0.53375806 |
| 112 | PLK4 | 0.53325439 |
| 113 | ABL1 | 0.53250961 |
| 114 | CHUK | 0.53030970 |
| 115 | CDK18 | 0.51349236 |
| 116 | PIK3CG | 0.51288010 |
| 117 | SIK3 | 0.50464334 |
| 118 | BRSK2 | 0.49970671 |
| 119 | PINK1 | 0.49481118 |
| 120 | DAPK3 | 0.48787715 |
| 121 | TTK | 0.48690839 |
| 122 | MAP3K2 | 0.48629205 |
| 123 | PRKD2 | 0.47975714 |
| 124 | PIM1 | 0.47570687 |
| 125 | CAMKK1 | 0.47244155 |
| 126 | STK39 | 0.46747855 |
| 127 | IKBKE | 0.46591253 |
| 128 | LCK | 0.46512744 |
| 129 | RET | 0.46377339 |
| 130 | CSNK1G2 | 0.45026353 |
| 131 | IGF1R | 0.43769786 |
| 132 | ABL2 | 0.43356426 |
| 133 | NTRK1 | 0.42310733 |
| 134 | CDK15 | 0.42062720 |
| 135 | EPHB1 | 0.41989003 |
| 136 | PAK6 | 0.41058065 |
| 137 | OBSCN | 0.40831313 |
| 138 | CDK14 | 0.39629600 |
| 139 | LYN | 0.39346219 |
| 140 | CSNK1G1 | 0.38613725 |
| 141 | CDK11A | 0.38519952 |
| 142 | DYRK1B | 0.37861875 |
| 143 | NUAK1 | 0.37067490 |
| 144 | EPHA4 | 0.36600108 |
| 145 | FGFR3 | 0.36307963 |
| 146 | BTK | 0.35478279 |
| 147 | MARK1 | 0.35061064 |
| 148 | CDK9 | 0.35016550 |
| 149 | MAP3K5 | 0.34490960 |
| 150 | CSK | 0.34233197 |
| 151 | IRAK1 | 0.34093771 |
| 152 | CSNK1G3 | 0.33806216 |
| 153 | DMPK | 0.32908386 |
| 154 | CDK6 | 0.32234102 |
| 155 | RPS6KC1 | 0.30548969 |
| 156 | RPS6KL1 | 0.30548969 |
| 157 | MAPKAPK2 | 0.30344970 |
| 158 | RPS6KA6 | 0.28906788 |
| 159 | MAP3K13 | 0.28631753 |
| 160 | PIK3CA | 0.27859779 |
| 161 | PAK3 | 0.26339350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.41170497 |
| 2 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 3.10163201 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.87816924 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.86408680 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.54453394 |
| 6 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.35737477 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.31554809 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 2.23255242 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.06119419 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 1.94725867 |
| 11 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.90094335 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88656373 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.84388262 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83943662 |
| 15 | Amoebiasis_Homo sapiens_hsa05146 | 1.80126074 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76813112 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.67447381 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66633509 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.59557228 |
| 20 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.54995758 |
| 21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.54776499 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.53467798 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53106871 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.52104507 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.49571939 |
| 26 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.44961260 |
| 27 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.36591663 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.36492112 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.36200111 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34902226 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.33886102 |
| 32 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.32984392 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.32663946 |
| 34 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.32391054 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29119963 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.26168238 |
| 37 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.23655431 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23393809 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22138331 |
| 40 | Protein export_Homo sapiens_hsa03060 | 1.21645707 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21077855 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.19854033 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19275483 |
| 44 | Adherens junction_Homo sapiens_hsa04520 | 1.19186824 |
| 45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.17122325 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15072881 |
| 47 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.14571458 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.14034883 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12559005 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 1.11647369 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.09666638 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.08824628 |
| 53 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.08293352 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 1.07695512 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07670578 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06935754 |
| 57 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.06331731 |
| 58 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.06245476 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05274576 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04903650 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04790677 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.04672248 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04241705 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04067536 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 1.03997320 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.03487005 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03073057 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 1.02222295 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99126344 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98902690 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.98497913 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.97541315 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.96720414 |
| 74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93914392 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.92062026 |
| 76 | Axon guidance_Homo sapiens_hsa04360 | 0.91235124 |
| 77 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.90218102 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89774613 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.89152975 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88913129 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87533057 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86510214 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.85909378 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85779236 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85493974 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85290216 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85044752 |
| 88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.84558005 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.84298908 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83000162 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81476281 |
| 92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81212982 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.80070667 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79996779 |
| 95 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79262700 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78576934 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77161595 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74666781 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74638534 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74381627 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73628118 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73270935 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71703231 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.71614025 |
| 105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.71438174 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70461818 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70350377 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70037393 |
| 109 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69288295 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69103509 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68840072 |
| 112 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67552331 |
| 113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67350885 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67064074 |
| 115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66779702 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63330158 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61981240 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61046911 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.60411944 |
| 120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60034614 |
| 121 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59007092 |
| 122 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57825801 |
| 123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57029047 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56993320 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56778793 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55368245 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.54332381 |
| 128 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53825071 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53014728 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.52178642 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.51895326 |
| 132 | Allograft rejection_Homo sapiens_hsa05330 | 0.51463130 |
| 133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50780162 |
| 134 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48726156 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47900172 |
| 136 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47798969 |
| 137 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47631211 |
| 138 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46832363 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.45804510 |
| 140 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44307331 |
| 141 | Peroxisome_Homo sapiens_hsa04146 | 0.42768405 |
| 142 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41913562 |
| 143 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41685005 |
| 144 | Cell cycle_Homo sapiens_hsa04110 | 0.41475602 |
| 145 | Asthma_Homo sapiens_hsa05310 | 0.40074001 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37423674 |
| 147 | RNA degradation_Homo sapiens_hsa03018 | 0.34376960 |
| 148 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32972248 |
| 149 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32598731 |
| 150 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30044201 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29306159 |
| 152 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26891875 |

